Healthcare

Washington, DC – Nearly 7 in 10 Americans with type II diabetes think that it is important to know their glucose levels on a regular basis.

This paper provides an overview of the treatment approaches for Multiple Sclerosis (MS) in 2016, together with an exploration of the current market dynamics and how they have evolved in recent years. It concludes with two case studies: 'Tecfidera: Still The Wonder Drug?' and 'Analysing Key Market Drivers'.

Our clients often ask us, who uses our syndicated data? How, where and why do they use it...?

Marco DiBonaventura Joins Ipsos Healthcare in a Senior Global Role, and Richard W. Martin and Elizabeth Machado Assume North American Posts

Who is using a connected health device and why? Who or what is really influencing uptake? How do doctors, patients and the general public perceive the future of connected health...?

Ipsos Healthcare reveals top-line findings from the first Ipsos International survey on connected health

Ipsos Healthcare and HoneyB Health Partner to Explore How Patients and Practitioners Use Connected Health Technologies